Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism MDA5 inhibitors(interferon induced with helicase C domain 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Infectious Diseases | Discovery | - | 02 Oct 2025 | |
| Infectious Diseases | Discovery | - | 02 Oct 2025 | |
| Infectious Diseases | Discovery | - | 02 Oct 2025 | |
| Neoplasms | Discovery | - | 02 Oct 2025 | |
| Neoplasms | Discovery | - | 02 Oct 2025 | |
| Neoplasms | Discovery | - | 02 Oct 2025 |





